Correlation Between Ambrx Biopharma and Effector Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ambrx Biopharma and Effector Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ambrx Biopharma and Effector Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ambrx Biopharma American and Effector Therapeutics, you can compare the effects of market volatilities on Ambrx Biopharma and Effector Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ambrx Biopharma with a short position of Effector Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ambrx Biopharma and Effector Therapeutics.
Diversification Opportunities for Ambrx Biopharma and Effector Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Ambrx and Effector is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Ambrx Biopharma American and Effector Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Effector Therapeutics and Ambrx Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ambrx Biopharma American are associated (or correlated) with Effector Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Effector Therapeutics has no effect on the direction of Ambrx Biopharma i.e., Ambrx Biopharma and Effector Therapeutics go up and down completely randomly.
Pair Corralation between Ambrx Biopharma and Effector Therapeutics
If you would invest 13.00 in Effector Therapeutics on November 4, 2024 and sell it today you would earn a total of 0.00 from holding Effector Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Ambrx Biopharma American vs. Effector Therapeutics
Performance |
Timeline |
Ambrx Biopharma American |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Ambrx Biopharma and Effector Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ambrx Biopharma and Effector Therapeutics
The main advantage of trading using opposite Ambrx Biopharma and Effector Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ambrx Biopharma position performs unexpectedly, Effector Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Effector Therapeutics will offset losses from the drop in Effector Therapeutics' long position.Ambrx Biopharma vs. Immix Biopharma | Ambrx Biopharma vs. Cns Pharmaceuticals | Ambrx Biopharma vs. Sonnet Biotherapeutics Holdings | Ambrx Biopharma vs. Enveric Biosciences |
Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |